Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB
机构：[1]Department of Hematology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[2]Hongqiao International Institute of Medicine, Shanghai Tongren Hospital,Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education[3]Shanghai JiaoTong University School of Medicine[4]State Key Laboratory of Experimental Hematology, Shanghai, Chin
第一作者机构：[1]Department of Hematology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[2]Hongqiao International Institute of Medicine, Shanghai Tongren Hospital,Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education[3]Shanghai JiaoTong University School of Medicine[4]State Key Laboratory of Experimental Hematology, Shanghai, Chin
推荐引用方式(GB/T 7714)：
Liu Ligen,Zhai Yuanmmei,Yang Li,et al.Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB[J].BLOOD.2021,138:3685-+.doi:10.1182/blood-2021-144631.
APA：
Liu, Ligen,Zhai, Yuanmmei,Yang, Li,Zhao, Limin,Chang, Li...&Zhang, Zhizhi.(2021).Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB.BLOOD,138,
MLA：
Liu, Ligen,et al."Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB".BLOOD 138.(2021):3685-+
医学